Behavioral Intervention for Type 1 Diabetes
(EMPoWER Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The EMPoWER Study randomized clinical trial is a strengths-based behavioral intervention delivered to youth with type 1 diabetes (age 10 to 13) and their parents. The purpose of the intervention is to improve glycemic, behavioral, and psychosocial outcomes in youth with diabetes using a multiple systems approach that engages youth, their parents, and diabetes care providers to identify and build youths' diabetes strengths. The primary aim of this study is to assess the intervention impact on glycemic control, adherence, and health-related quality of life (HRQOL). Secondary aims are to evaluate behavioral mediators of intervention impact and to examine intervention dose as a mediator of intervention impact.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on behavioral interventions rather than medication changes.
Is the behavioral intervention for Type 1 Diabetes safe for humans?
How is the behavioral intervention treatment for Type 1 Diabetes different from other treatments?
This behavioral intervention is unique because it focuses on teaching self-management skills and promoting adherence to diabetes care through psychological and educational support, rather than relying solely on medication. It often involves family participation and may use technology like mobile apps to engage adolescents, making it different from traditional medical treatments that focus on insulin and blood sugar control.16789
What data supports the effectiveness of the treatment Teen Videos, Behavioral Intervention Videos, Educational Videos for Type 1 Diabetes?
Research shows that educational and behavioral interventions can help improve diabetes knowledge and self-care in children and adolescents with type 1 diabetes. Behavioral interventions, especially those involving coping skills and peer support, have been found to assist adolescents in better managing their condition.1671011
Who Is on the Research Team?
Marisa Hilliard, PhD
Principal Investigator
Baylor College of Medicine
Are You a Good Fit for This Trial?
This trial is for English-speaking teens aged 14-17 living in the US with type 1 diabetes for at least a year. It's not suitable for those with major psychiatric or developmental disorders, or serious medical conditions like cancer or cystic fibrosis.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Orientation and Randomization
Parent-youth dyads complete an orientation session and are randomized to their study arm
Intervention
Participants engage in the T1DW Program or EUC Program for 6 months, involving app-based activities or monthly handouts
Follow-up
Participants are monitored for safety and effectiveness after the intervention, including satisfaction surveys and other assessments
What Are the Treatments Tested in This Trial?
Interventions
- Teen Videos
Find a Clinic Near You
Who Is Running the Clinical Trial?
Baylor College of Medicine
Lead Sponsor
Children's National Research Institute
Collaborator